314
Participants
Start Date
September 13, 2023
Primary Completion Date
August 12, 2024
Study Completion Date
December 3, 2024
GSK3858279
GSK3858279 will be administered.
Placebo
Placebo will be administered.
GSK Investigational Site, Ciudad AutOnoma de Buenos Aire
GSK Investigational Site, Gauteng
GSK Investigational Site, Buenos Aires-San Isidro
GSK Investigational Site, Sydney
GSK Investigational Site, Botany
GSK Investigational Site, Johannesburg
GSK Investigational Site, Kotara
GSK Investigational Site, Camberwell
GSK Investigational Site, Cape Town
GSK Investigational Site, Cape Town
GSK Investigational Site, Stellenbosch
GSK Investigational Site, Berlin
GSK Investigational Site, Williamsville
GSK Investigational Site, A Coruña
GSK Investigational Site, Santiago de Compostela
GSK Investigational Site, Duncansville
GSK Investigational Site, La Rochelle
GSK Investigational Site, Hamburg
GSK Investigational Site, Mexicali
GSK Investigational Site, Hamburg
GSK Investigational Site, Charlottesville
GSK Investigational Site, Torreón
GSK Investigational Site, Greensboro
GSK Investigational Site, Madrid
GSK Investigational Site, Chihuahua City
GSK Investigational Site, Cooper City
GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, Cutler Bay
GSK Investigational Site, Montpellier
GSK Investigational Site, Santander
GSK Investigational Site, Magdeburg
GSK Investigational Site, Dax
GSK Investigational Site, Louisville
GSK Investigational Site, Seville
GSK Investigational Site, Guadalajara
GSK Investigational Site, Wichita
GSK Investigational Site, New Orleans
GSK Investigational Site, Paris
GSK Investigational Site, La Roche-sur-Yon
GSK Investigational Site, Henderson
GSK Investigational Site, Cerritos
GSK Investigational Site, Huntington Beach
GSK Investigational Site, Santa Clara
GSK Investigational Site, Beijing
GSK Investigational Site, Beijing
GSK Investigational Site, Shenyang
GSK Investigational Site, Changchun
GSK Investigational Site, Shanghai
GSK Investigational Site, Shanghai
GSK Investigational Site, Shanghai
GSK Investigational Site, Nanjing
GSK Investigational Site, Tianjin
GSK Investigational Site, Zhuzhou
GSK Investigational Site, Guangzhou
GSK Investigational Site, Chengdu
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Ciudad Autonoma Buenos Aires
GSK Investigational Site, Ciudad Autonoma de Buenos Aire
GSK Investigational Site, Mar del Plata
GSK Investigational Site, Victoria
GSK Investigational Site, Brampton
GSK Investigational Site, Guelph
GSK Investigational Site, Sarnia
GSK Investigational Site, Toronto
GSK Investigational Site, Toronto
GSK Investigational Site, Winchester
GSK Investigational Site, Joliette
GSK Investigational Site, Sherbrooke
GSK Investigational Site, Trois-Rivières
GSK Investigational Site, Hohhot
GSK Investigational Site, Shijiazhuang
GSK Investigational Site, Fukuoka
GSK Investigational Site, Ibaraki
GSK Investigational Site, Ibaraki
GSK Investigational Site, Nagano
GSK Investigational Site, Nagano
GSK Investigational Site, Osaka
GSK Investigational Site, Saitama
GSK Investigational Site, Shimane
GSK Investigational Site, Tokyo
GSK Investigational Site, Tokyo
GSK Investigational Site, Tokyo
GSK Investigational Site, Mérida
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Blackpool
GSK Investigational Site, Cannock
GSK Investigational Site, London
GSK Investigational Site, Manchester
Lead Sponsor
GlaxoSmithKline
INDUSTRY